Cargando…
Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection
BACKGROUND: Cardiac allograft rejection remains a significant clinical problem in the early phase after heart transplantation and requires frequent surveillance with endomyocardial biopsy. However, this is an invasive procedure, which is unpleasant for the patient and carries a certain risk. Therefo...
Autores principales: | Karason, Kristjan, Jernås, Margareta, Hägg, Daniel A, Svensson, Per-Arne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1569871/ https://www.ncbi.nlm.nih.gov/pubmed/16780603 http://dx.doi.org/10.1186/1471-2261-6-29 |
Ejemplares similares
-
Association between CXCL9/10 polymorphisms and acute rejection of liver allograft
por: Ostojic, Ana, et al.
Publicado: (2019) -
CXCL8, CXCL9, CXCL10, and CXCL11 as biomarkers of liver injury caused by chronic hepatitis B
por: Yu, Xin, et al.
Publicado: (2022) -
Association of circulating CXCL10 and CXCL11 with systemic sclerosis
por: Crescioli, Clara, et al.
Publicado: (2018) -
CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory T cells in a mouse retransplantation model
por: ZHUANG, JIAWEI, et al.
Publicado: (2014) -
CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients
por: Wang, Cuini, et al.
Publicado: (2016)